Matsumoto Shinya, Akahane Manabu, Kanagawa Yoshiyuki, Kajiwara Jumboku, Mitoma Chikage, Uchi Hiroshi, Furue Masutaka, Imamura Tomoaki
Department of Public Health, Health Management and Policy, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, Japan.
Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka, Japan.
Environ Health. 2015 Sep 17;14:76. doi: 10.1186/s12940-015-0059-y.
Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the 'Yusho incident' in 1968 found that in some the half-life of blood 2,3,4,7,8-PeCDF tended towards infinity. This suggests that there are two groups of Yusho patients, those with 2,3,4,7,8-PeCDF half-lives around 10 years, and those with half-lives near infinity. We sought to establish the proportions of each in a cohort of 395 Yusho patients, and whether the proportions were changing over time.
We undertook longitudinal measurement of the blood concentration of 2,3,4,7,8-PeCDF in our cohort between 2002 and 2010. We estimated the change in concentration for each patient using linear regression for measured 2,3,4,7,8-PeCDF concentration, then compared the distribution of changes in concentrations with our previous study.
In patients in whom the blood concentration of 2,3,4,7,8-PeCDF exceeded 50 pg/g lipid, the proportion 8.0% of patients exhibiting half-lives less than 13.3 years fell compared with our previous study (28.2%), while the proportion with near infinity half-lives increased.
The prolongation of the half-lives was likely a consequence of age-related factors.
二噁英及二噁英类化合物的半衰期通常在7.2年至15年之间。我们之前对1968年“油症事件”中因极高浓度的2,3,4,7,8 - 五氯二苯并呋喃(PeCDF)中毒的患者进行的研究发现,部分患者血液中2,3,4,7,8 - PeCDF的半衰期趋于无穷大。这表明油症患者可分为两组,一组患者血液中2,3,4,7,8 - PeCDF的半衰期约为10年,另一组患者的半衰期接近无穷大。我们试图确定395名油症患者中每组的比例,以及这些比例是否随时间变化。
我们在2002年至2010年期间对该队列中患者血液中2,3,4,7,8 - PeCDF的浓度进行了纵向测量。我们使用线性回归分析测量的2,3,4,7,8 - PeCDF浓度,估算每位患者的浓度变化,然后将浓度变化的分布与我们之前的研究进行比较。
血液中2,3,4,7,8 - PeCDF浓度超过50 pg/g脂质的患者中,半衰期小于13.3年的患者比例为8.0%,与我们之前的研究(28.2%)相比有所下降,而半衰期接近无穷大的患者比例有所增加。
半衰期延长可能是与年龄相关因素的结果。